Myriad Genetics Inc (MYGN)

28.16 -0.32  -1.12% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All MYGN News

News

View All Events

Events

Date Type Description
05/05/2020 16:30 EDT Earnings Calls Q3 2020 Earnings Call
05/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
08/13/2020 16:30 EDT Earnings Calls Q4 2020 Earnings Call
08/13/2020 00:00 Earnings Results Q4 2020 Earnings Results
11/09/2020 00:00 Earnings Results Q1 2021 Earnings Results
11/09/2020 17:00 EST Earnings Calls Q1 2021 Earnings Call
12/04/2020 08:00 MST Agm 2020 Annual General Meeting
02/23/2021 00:00 Earnings Results Q2 2021 Earnings Results
02/23/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 00:00 Earnings Results Q3 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.myriad.com
  • Investor Relations URL: https://myriad.com/news-center/investor-information/
  • HQ State/Province: Utah
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 05, 2021
  • Last Earnings Release: Feb. 23, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Myriad Genetics is a molecular diagnostics company, which provides testing services designed to assess an individual’s risk of developing a disease. The firm produces myRisk, a 35-gene panel with the capability to identify the elevated risk of developing 8 types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Vectra DA, which predicts disease progression in rheumatoid arthritis to optimize drug treatment; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 2.62%
GNOM Global X Genomics & Biotechnology ETF 2.32%
PSCH Invesco S&P SmallCap Health Care ETF 1.86%
PMJPX PIMCO RAE US Small I-2 0.66%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.